ArticleFrontiers in pediatrics2026
Case Report: Early surgical intervention for epilepsy with mild MOGHE: timing and clinical efficacy.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE) is a new histopathological entity identified in resected brain tissue from patients with drug-resistant epilepsy. Clinically, this epilepsy subtype most commonly presents as epileptic spasms in early childhood. Conventional anatomical-electro-clinical approaches struggle to accurately delineate the epileptogenic zone, posing substantial challenges to clinical management. Case description: This paper reports a 2-year-and-11-month-old male infant who developed significant intellectual and language regression merely 3 months after the onset of epileptic seizures. Scalp video-electroencephalography (VEEG) demonstrated generalized epileptiform discharges, cranial magnetic resonance imaging (MRI) revealed abnormal signals in the left frontal lobe, and fused cranial 18F-fluorodeoxyglucose positron emission tomography (PET)-MRI imaging showed no obvious hypometabolic foci. Following oral vigabatrin administration, clinical seizures were absent, yet neurodevelopmental regression progressed continuously. For children with early-onset developmental regression, a clinical decision-making dilemma exists: whether to continue medication adjustment and await fulfillment of traditional drug-resistant epilepsy criteria before surgery, or to implement active early surgical intervention. Conclusion: Through full-course follow-up of this child with MOGHE-associated epilepsy, this study integrated the evolution of clinical symptoms, electroencephalographic characteristics, imaging findings, and treatment responses to explore the rationale for surgical timing selection. The results suggest that for childhood epilepsy caused by definite cerebral structural abnormalities (particularly MOGHE) that has already led to obvious neurodevelopmental regression, active early surgical treatment should be considered to prevent disease progression and create favorable conditions for subsequent rehabilitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.